Advisor OS’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,830
Closed -$642K 594
2025
Q4
$642K Buy
1,830
+58
+3% +$19.6K 0.05% 243
2025
Q3
$573K Buy
1,772
+102
+6% +$31.7K 0.05% 236
2025
Q2
$650K Buy
1,670
+1,075
+181% +$432K 0.06% 211
2025
Q1
$259K Buy
+595
New +$239K 0.03% 357
2024
Q3
Sell
-380
Closed -$206K 414
2024
Q2
$206K Buy
+380
New +$201K 0.02% 374
2024
Q1
Sell
-551
Closed -$260K 393
2023
Q4
$260K Buy
+551
New +$255K 0.03% 281

Other funds holding ELV

Advisor OS's ELV Position: Q1 2026 in Review

Advisor OS sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 1,830 shares — an estimated $642K sold.

Advisor OS first reported a position in ELV in Q4 2023 and held it in 6 quarters. The position peaked at $650K in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Advisor OS reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Advisor OS sold 1,830 Elevance Health shares in Q1 2026, an estimated $642K.
  • Advisor OS first reported a position in Elevance Health in Q4 2023 and held it in 6 quarters.
  • Advisor OS's Elevance Health position peaked at $650K in Q2 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Advisor OS's 13F filing for Q1 2026, filed 8 May 2026.